摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(Methylamino)spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-1'-one

中文名称
——
中文别名
——
英文名称
4-(Methylamino)spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-1'-one
英文别名
——
4-(Methylamino)spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-1'-one化学式
CAS
——
化学式
C13H16N2O2
mdl
——
分子量
232.282
InChiKey
OVUQXFGYEZPVBX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    51.2
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (5-苯基吡嗪-2-基)氨基甲酸苯酯4-(Methylamino)spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-1'-one 生成 1-methyl-1-[1'-oxospiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridin]-4-yl]-3-(5-phenylpyrazin-2-yl)urea
    参考文献:
    名称:
    Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor
    摘要:
    A novel series of spirocyclic derivatives was synthesized and evaluated as NPY Y5R antagonists for the treatment of obesity. Cis and trans analogs 7a and 8a were equipotent in a Y5R binding assay (K-i's <= 1 nM) and displayed good stability in human and rat liver microsome preparations. Compound 7a failed to demonstrate weight loss activity in a diet-induced obese (DIO) rat model at unbound drug levels in the brain that exceeded the Y5R K-i value by 25-fold over a 24-h time-period. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.02.098
  • 作为产物:
    描述:
    螺[环己烷-1,3(1H)-呋喃并[3,4-c]吡啶]-1,4-二酮甲胺titanium(IV) isopropylate 、 sodium tetrahydroborate 作用下, 以 乙醇 为溶剂, 以41%的产率得到4-(Methylamino)spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-1'-one
    参考文献:
    名称:
    Practical Synthesis of (1s,4s)-4-(Methylamino)-1′H-spiro[cyclohexane-1,3′-furo[3,4-c]pyridin]-1′-one
    摘要:
    A practical and scalable process for the preparation of (1s,4s)-4-(methylamino)-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridin]-1'-one 2a, a highly functionalized and potentially useful building block for pharmaceutical research is described. The material is prepared via an efficient two-step sequence from readily available materials and is isolated as a single diastereomer in high chemical purity.
    DOI:
    10.1021/op100138t
点击查看最新优质反应信息

文献信息

  • Practical Synthesis of (1<i>s</i>,4<i>s</i>)-4-(Methylamino)-1′<i>H</i>-spiro[cyclohexane-1,3′-furo[3,4-<i>c</i>]pyridin]-1′-one
    作者:Gerwyn Bish、Pieter D. de Koning、Stephané P. A. Dubant、David Fengas、M. Jonathan Fray
    DOI:10.1021/op100138t
    日期:2010.9.17
    A practical and scalable process for the preparation of (1s,4s)-4-(methylamino)-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridin]-1'-one 2a, a highly functionalized and potentially useful building block for pharmaceutical research is described. The material is prepared via an efficient two-step sequence from readily available materials and is isolated as a single diastereomer in high chemical purity.
  • Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor
    作者:Michael Fichtner、Eunsun Lee、Elizabeth Tomlinson、Dennis Scott、Peter Cornelius、Terrell A. Patterson、Philip A. Carpino
    DOI:10.1016/j.bmcl.2012.02.098
    日期:2012.4
    A novel series of spirocyclic derivatives was synthesized and evaluated as NPY Y5R antagonists for the treatment of obesity. Cis and trans analogs 7a and 8a were equipotent in a Y5R binding assay (K-i's <= 1 nM) and displayed good stability in human and rat liver microsome preparations. Compound 7a failed to demonstrate weight loss activity in a diet-induced obese (DIO) rat model at unbound drug levels in the brain that exceeded the Y5R K-i value by 25-fold over a 24-h time-period. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-